Natural History of the Progression of X-Linked Retinitis Pigmentosa
Completed
Conditions studied: X-Linked Retinitis Pigmentosa
In brief
The objective of the study is to gain a better understanding of disease progression over time in participants with X-linked retinitis pigmentosa (XLRP).
Key facts
- Study ID
- NCT04926129
- Run by
- NightstaRx Ltd, a Biogen Company
- People needed
- 201
- Starts
- 2017-09-13
- Expected to finish
- 2022-12-16
- Last updated by the study team
- 2023-02-10
Who can join
Age: 7 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Phoenix, Arizona, United States
- Research Site — Los Angeles, California, United States
- Research Site — San Francisco, California, United States
- Research Site — Miami, Florida, United States
- Research Site — New York, New York, United States
- Research Site — Portland, Oregon, United States
- Research Site — Dallas, Texas, United States
- Research Site — Houston, Texas, United States
- Research Site — Salt Lake City, Utah, United States
- Research Site — Madison, Wisconsin, United States
- Research Site — Montreal, Quebec, Canada
- Research Site — Vancouver, Canada
- Research Site — Helsinki, Finland
- Research Site — Montpellier, France
- Research Site — Bonn, Germany
- Research Site — Tübingen, Germany
- Research Site — Leiden, Netherlands
- Research Site — Nijmegen, Netherlands
- Research Site — Leeds, United Kingdom
- Research Site — Manchester, United Kingdom
- Research Site — Oxford, United Kingdom
- Research Site — Southampton, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.